Necrotizing enterocolitis (NEC) is a severe pathological condition characterized by intestinal tissue necrosis, which can lead to organ death and serious complications, including sepsis. This disease is most often observed in premature infants, but can also occur in low birth weight infants and infants with other risk factors. NEC is a multifactorial disease, and its pathogenesis includes vasomotor regulation disorders, hypoxia, as well as the effects of bacterial flora and mechanical damage to the intestinal wall. Clinical manifestations can vary from mild to severe, and require immediate medical attention to prevent progression of the condition.
History of the disease and interesting historical facts
Necrotizing enterocolitis was first described in the early 20th century, but cases had been reported earlier. In the 1950s, scientists began to more thoroughly investigate the pathophysiology of NEC, identifying its association with prematurity and low birth weight infants. One of the first studies conducted in the 1960s was a study of clinical cases of NEC in neonatal units. Interestingly, before the advent of modern treatments, systematic observation showed high mortality among affected infants, highlighting the need to develop new therapeutic strategies. In the 1990s, the active introduction of probiotics began, which led to a noticeable decrease in cases of the disease in premature infant units.
Epidemiology
Statistics on necrotizing enterocolitis show that this disease primarily affects premature infants, especially those weighing less than 1500 grams. According to studies, the prevalence of NEC varies from 11% to 71% among premature infants, depending on the sustainability of health care facilities and the use of modern nursing technologies. Mortality from NEC ranges from 20% to 50%, and even if they survive, children may face long-term consequences such as intestinal failure and developmental delay. In recent decades, much research has been conducted to identify methods to reduce the incidence of the disease, including early introduction of breast milk and probiotics.
Genetic predisposition to this disease
Genetic predisposition to necrotizing enterocolitis is not the only factor, but some studies point to certain gene mutations and polymorphisms that may be associated with an increased risk of the disease. These include the following genes:
- TLR4 is a gene encoding Toll-like receptor 4, which is involved in the immune response and may influence susceptibility to infections.
- IL-10 is the interleukin 10 gene, which plays a key role in the regulation of inflammatory processes.
- MMP-9 is a matrix metalloproteinase 9 that is involved in extracellular matrix remodeling and may influence tissue healing.
These genes may influence the immune response and the integrity of the intestinal barrier. Studies suggest that children with certain genetic changes may have an increased risk of developing NEC, but questions about the applicability of genetic screening in clinical practice remain open.
Risk factors for the development of this disease
Necrotic enterocolitis is associated with a number of risk factors, which can be divided into physical and chemical:
- Prematurity (especially with a weight of less than 1500 grams).
- Individual intolerance or allergy to milk components.
- Hemodynamic disturbances, including hypotension and shock.
- Gastrointestinal tract pathology, including congenital anomalies.
- Infectious diseases such as infectious sepsis.
It should also be taken into account that the use of certain medical interventions, such as mechanical ventilation and parenteral nutrition, may increase the risk of developing NEC.
Diagnosis of this disease
Diagnosis of necrotizing enterocolitis includes a comprehensive clinical and laboratory examination:
- The main symptoms are: the appearance of bloody discharge from the intestines, bloating, flatulence, lack of appetite and a severe general condition of the child.
- Laboratory tests: complete blood count (leukocytosis, thrombocytopenia), biochemical analysis (increased creatinine and lactate levels).
- Radiological examinations: abdominal X-ray to detect signs of intestinal obstruction or perforation.
- Other types of diagnostics: ultrasound of the abdominal cavity to assess the condition of the intestines and the presence of free fluid.
- Differential diagnosis: other conditions such as infectious enteritis and tolkodrealizaton must be excluded.
Monitoring the dynamics of symptoms and test results is key to confirming or refuting the diagnosis of NEC.
Treatment
Treatment of necrotizing enterocolitis requires a varied approach:
- General treatment includes supportive care, including correction of electrolyte disturbances and provision of adequate nutrition.
- Pharmacological treatment is aimed at correcting infectious concomitant conditions, usually using broad-spectrum antibiotics.
- Surgical treatment is indicated in cases accompanied by intestinal perforation, peritonitis or necrosis of large areas.
- Other treatments may include the use of probiotics in early postnatal care to reduce morbidity.
Planning and implementation of treatment require a high degree of attention from neonatologists and surgeons, as any delayed intervention can lead to serious consequences.
List of medications used to treat this disease
Medications used to treat NEC include:
- Antibiotics: ampicillin, gentamicin, metronidazole.
- Antifungal agents: fluconazole.
- Preparations for the correction of electrolyte disturbances: Ringer's or Hartmann's solutions.
- Supportive medications: insulin if necessary to control metabolism.
Timely administration of these drugs can significantly affect the outcome of the disease.
Disease monitoring
Monitoring the condition of a patient with NEC is critically important for identifying the dynamics of the clinical course and adjusting therapy:
- Control steps include regular assessment of laboratory parameters, monitoring of general condition and physical examination.
- The prognosis depends on the severity of the disease, the speed of diagnosis and the start of treatment; the earlier the therapy is started, the better the outcome.
- Complications may include intestinal obstruction, peritonitis and, in the worst case, sepsis, which requires immediate intervention.
Mortality in NEC remains significant and the potential consequences for each individual patient must be considered.
Age-related features of the disease
Necrotic enterocolitis is most often found in premature infants, however, certain age-related features of its course can be identified:
- Premature babies: There is a high risk of developing NEC due to the immaturity of organs and systems, including the immune system.
- In full-term infants: NEC may be less common, but they are also at risk due to other predisposing factors such as infection or injury.
- In elderly adults: NEC may manifest as a secondary pathology against the background of chronic pathology, complicating the clinical island.
Each age group has its own characteristics that must be taken into account when diagnosing and treating NEC.
Questions and Answers
- What is necrotizing enterocolitis? This is a severe disease in which the intestinal wall becomes necrotic, most often seen in premature infants.
- What factors increase the risk of developing NEC? The main factors include prematurity, low birth weight, infections and hemodynamic disturbances.
- How is necrotizing enterocolitis diagnosed? Diagnosis includes clinical manifestations, laboratory tests, radiography and ultrasound diagnostics.
- What is the treatment for NEC? Treatment can be conservative (supportive therapy, antibiotics) or surgical (in case of perforation or large necrotic areas).
- What is the prognosis for NEC? The prognosis depends on the speed of diagnosis and initiation of treatment, but overall mortality can reach 50% in severe forms of the disease.
